|
|
Article: Roche's Xenical shows greater benefit in early responders.(product development)(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- September 11, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Swiss drug major Roche says that its weight-loss medication Xenical (orlistat) can safely help obese adolescents lose excess weight, providing not only a major health benefit but also considerable improvements in self-esteem and quality of life.
According to data presented at the International Congress on Obesity, held in Sydney, Australia, those teenagers who experienced greater weight loss during the first three months of treatment also achieved an average weight loss over three times greater that those with a slower response.
The retrospective analysis looked at obese adolescents aged 12-16 ...